alexa Contact-Independent Antagonism of Ophidiomyces ophiodiicola, the Causative Agent of Snake Fungal Disease by Rhodococcus rhodochrous DAP 96253 and Select Volatile Organic Compounds
ISSN: 2157-7579
Journal of Veterinary Science & Technology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Contact-Independent Antagonism of Ophidiomyces ophiodiicola, the Causative Agent of Snake Fungal Disease by Rhodococcus rhodochrous DAP 96253 and Select Volatile Organic Compounds

Christopher T Cornelison*, Blake Cherney, Kyle T Gabriel, Courtney K Barlament and Sidney A Crow Jr

Applied and Environmental Microbiology, Georgia State University, Atlanta, GA, USA

*Corresponding Author:
Christopher T Cornelison
Senior Scientist, Applied and Environmental Microbiology
Georgia State University, 161 Dr. Jesse Hill Jr.
Atlanta, Georgia 30303, United States of America
Tel: 4044135202
E-mail: [email protected]

Received Date: October 18, 2016; Accepted Date: October 25, 2016; Published Date: October 31, 2016

Citation: Cornelison CT, Cherney B, Gabriel KT, Barlament CK, Crow Jr SA (2016) Contact-Independent Antagonism of Ophidiomyces ophiodiicola, the Causative Agent of Snake Fungal Disease by Rhodococcus rhodochrous DAP 96253 and Select Volatile Organic Compounds. J Vet Sci Technol 7:397. doi: 10.4172/2157- 7579.1000397

Copyright: © 2016 Cornelison CT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Veterinary Science & Technology

Abstract

Snake fungal disease (SFD), caused by the ascomycete Ophidiomyces ophiodiicola, has been associated with severe morbidity and mortality of numerous species of wild snakes in 15 US states. Accordingly, SFD was added to the horizon scan of global conservation issues in 2014. Due to the itinerant and secluded nature of many snake species, as well as the diversity of species impacted by SFD, estimating SFD-associated mortalities has been challenging. Regardless, the impacts have been shown to be significant in local and regional instances. Currently there is no known therapeutic or prophylactic for SFD. This study evaluated a potential biological treatment option for SFD that has shown promise in managing white-nose syndrome in bats, the bacterium Rhodococcus rhodochrous DAP 96253. R. rhodochrous was evaluated for in vitro contact-independent antagonism of O. ophiodiicola, with positive results. Additionally, synthetic volatile organic compounds (VOCs) associated with fungistatic soils were evaluated individually and in combinations to determine their potential for use as chemical control agents of SFD. In all cases an inhibitory effect was observed and statistically significant (p<0.05) radial growth inhibition was observed in several cases. The results presented in this study provide initial evidence for the in vivo evaluation of the potential of these agents to prevent or reduce the morbidity and mortality associated with SFD.

Keywords

Rhodococcus; Ophidiomyces; Snakes; VOCs; Antagonism

Introduction

Beginning in 2006, an increasing number of snakes infected with a fungal dermatitis has been reported [1]. Cases have been confirmed in Florida, Georgia, Illinois, Massachusetts, Michigan, Minnesota, New Jersey, New York, Ohio, Tennessee, Wisconsin, and Virginia [1,2]. This disease is commonly known as snake fungal disease (SFD), and is attributed to Ophidiomyces ophiodiicola as the causative agent [3,4]. Most snakes develop symptoms of brittle scales, subcutaneous nodules, severe swelling in the periocular tissues, and premature shedding [1,2,5,6]. Most case studies on SFD with vipers have reported lesions around the facial region, which negatively influence the snake’s ability to forage and survive in the wild [1,2,5,6]. The specific mechanism(s) of virulence and pathogenicity is currently unknown.

In 2014, SFD was declared in the horizon scan of global conservation issues due to the similar characteristics it shares with another fungal pathogen, Pseudogymnoascus destructans, the causative agent of whitenose syndrome (WNS) in bats [7]. The transmission route of SFD remains unknown, however, it is hypothesized to be environmentally transmitted due to the broad host range and annual cycle of infection [1,2,5,6]. Tracking the spread of this disease is very challenging due to the snake’s varied habitat and secretive lifestyle, indicating that cases likely exists outside the currently known range of SFD.

Population declines of venomous and nonvenomous snake species is of significant ecological concern as many species (e.g., eastern indigo snake, Drymarchon couperi) are considered keystone species in their respective ecosystems. Snakes play the fundamental role of middle predator in the environment, which keeps small mammal populations, such as rodents, under control [7,8]. Rodents are known vectors of human pathogens, which the Centers for Disease Control (CDC) states can cause over 35 diseases capable of being spread to humans through direct or indirect contact via bodily fluids [9]. Healthy and stable populations of middle predators, such as snakes, limit rodent populations, which decreases the likelihood of diseases transmission to humans. Additionally, research on snake venom is now used as a form of natural product for antivenins, anticoagulants, treating hemophilia, and studying neural toxins, myotoxins and their structure and function [10,11]. Snakes also play an enormous role in the private pet trade, amounting to an estimated total expenditure of $264 million a year in the US, making the US one of the largest exporters in this global industry [12].

With annually increasing reports of SFD, there is a growing concern for the health of snakes and the industries that rely on them, as well as the ecosystem services they provide. Clark et al. documented populations of the timber rattlesnake decreasing by 50 percent from 2006 to 2007 in New Hampshire [13]. Other states, such as Illinois, observed 100 percent mortality of massasauga rattlesnakes when infected with O. ophiodiicola [5]. Current antifungal treatments, such as ketoconazole and the surgical removal of an infected area, are often ineffective and lead to mortality [2,6].

Recently, a naturally-occurring Gram-positive bacterium, Rhodococcus rhodochrous was evaluated as a potential biological control agent for SFD. Previous research with this bacteria has shown promising results for the management of pathogenic fungal infections caused by P. destructans, the fungus responsible for the recent decline in bat populations in North America [14]. Given the similarity of traits between SFD and WNS, it was hypothesized that R. rhodochrous could have similar effects on O. ophiodiicola.

R. rhodochrous has a long history in industrial applications [15]. This bacterium has been used extensively in bioremediation due to its diverse metabolic activity, including the ability to breakdown complex hydrophobic pollutants as well as the bacterium’s presence in pristine and contaminated environments [15]. R. rhodochrous is also being evaluated for the ability to delay the ripening of climacteric fruits and vegetables to lengthen the shelf-life of human food stocks [16].

An additional line on inquiry in this study was evaluating the potential of naturally-occurring bacterially-produced volatile organic compounds (VOCs), associated with fungistatic soils, to inhibit the growth of O. ophiodiicola in vitro. Fungistatic soils occur globally and their antifungal activities are attributed to the generation of antagonistic VOCs by microbial community members [17-23]. Synthetically-produced VOCs were selected and introduced into a shared airspace with mycelia plugs to evaluate the antifungal activity of select VOCs. The compounds that were selected for this study were N, N dimethyloctylamine, benzothiazole, benzaldehyde, 2-phenylethanol, 2-ethyl-1-hexanol, propionic acid, 2-nonanone, decanal, styrene, and nonanal [17,19,21-23]. All compounds were introduced to fungal plug assays at 4 μmols. The five least toxic (based on LD50 with rats, S1) and the five most inhibitive (Table 1) were selected for combination trials of two and three VOCS to determine whether or not they have synergistic activities at equimolar ratios. Most fungistatic VOCs are produced by soil-dwelling bacteria [17,20]. There have been extensive studies conducted on fungistatic activity and the microbes that are correlated to the particular VOCs released into the soil [17-23]. Surveys of soil bacteria have reported that 30-60% of isolated microbiota produce VOCs that can inhibit fungi [20], indicative of the vast number of candidates not screened in this study and the potential of mining these communities for control agents for emerging fungal pathogens.

VOC Total area of mycelia (mm2) 7 days post inoculation
Nonanal 150.61
2-Ethyl-1-hexanol 204.13
Benzaldehyde 345.13
Propionic acid 365.23
N,N-Dimethyloctylamine 373.87
Decanal 378.95
2-Phenylethanol 418.93
Benzothiazole 638.96
2-Nonanone 650.02
Styrene 753.60
Control 681.85

Table 1: Averaged radial growth of single VOC exposures and control (most to least inhibitive). Each trial was performed in triplicate and the average of all exposures is represented below.

Current research showing induced cells of R. rhodochrous strain DAP 96253 and bacterially-produced VOCs as a possible treatment for WNS, establishes a precedent for this approach in the control of other emerging wildlife mycoses [14,18]. Initial in vitro evaluations of this approach in the management of SFD has been favourable and is presented below.

Materials and Methods

Culture acquisition and maintenance

Isolates of O. ophiodiicola (isolate number 10-1197) were obtained from the University of California Davis, School of Veterinary Medicine Department of Pathology, Microbiology & Immunology. Cultures were lawn streaked and grown on Sabouraud Dextrose Agar (SDA, Difco) then incubated for 7 to 10 days at 30°C or until the entire agar surface was covered with mycelial growth. Conidia of O. ophiodiicola were harvested according to the methods of Cornelison et al. [18]. For storage, the conidia solution was centrifuged at 3,000 rpm and the supernatant was removed. 10 ml of 25% glycerol solution was added to the resulting pellet and this mixture was vortexed. The conidia concentration was determined via hemocytometer (Bright-Line, Pennsylvania). Conidia solutions were stored at -80°C until use. All R. rhodochrous glycerol stock aliquots were prepared according to the methods of Pierce et al. [16,24,25]. Fresh glycerol stocks were used as the source of cells at the onset of each assay. The induction process was performed using the addition of either urea or urea and cobalt as described by Pierce et al. [16,24,25].

Co-culture assays with R. rhodochrous

Co-culture assays were carried out according to the methods of Cornelison et al. [14] and modified as follows. A Petri plate (60 mm × 15 mm) containing SDA was inoculated with 50 μl of O. ophiodiicola conidia solution (1.4 × 106 conidia ml-1) and placed in a shared airspace (150 mm × 15 mm) with cells of R. rhodochrous (treatment) or alone (control) and sealed with Parafilm M (Sigma-Aldrich, Missouri). All experimental setups remained sealed for 8 days or until the controls had formed a congruent mycelial lawn on the SDA (60 mm × 15 mm). All assays were performed in triplicate. In order to identify if R. rhodochrous has the ability to inhibit vegetative hyphae growth of O. ophiodiicola, mycelial plug assays were used to quantify the radial growth of O. ophiodiicola. A lawn of O. ophiodiicola was grown from conidia for 7-10 days and a 5 mm diameter transfer tube (Spectrum Medical, SC) was used to extract full depth mycelial plugs from the lawn of O. ophiodiicola. Each plug was then inserted into a fresh plate of SDA (60 mm × 15 mm). The resulting mycelial plug plates were placed into a shared airspace (150 mm × 15 mm) alone (control) or with two plates (60 mm × 15 mm) of induced R. rhodochrous (treatment) and sealed with Parafilm M.

Induced R. rhodochrous germule suppression assay

Germule suppression assays were conducted according to the methods of Cornelison et al. [14] and modified as follows. Slide agar overlays were inoculated with 50 μl of conidia suspension (1.4 × 106 conidia ml-1). Plates of induced R. rhodochrous were removed after 24 and 48 hours of exposure. Slide agars were then observed at 21 days post inoculation. Microscopic observation of slide agar overlays utilized a Nikon Eclipse model E600 (Japan) in Differential Interference Contrast (DIC). The camera used to capture photos was a Nikon D7000. A germule is defined as a mycelial extension from a single conidia greater than the length of the intact conidia.

Preparation of fermentation cell-paste in non-growth conditions

The preparation of fermentation cell paste was produced according to the methods of Pierce et al. [16,24,25]. Fermentation cell paste is a high cell density aggregate from 30L fermentations of R. rhodochrous DAP96253 that has been centrifuged to remove spent media. The assessment of anti-fungal activity of O. ophiodiicola was observed by mycelial plugs assays, with 1 and 2 grams of fermentation paste per shared airspace in treatment samples and no cell paste in controls.

VOC combination assay for anti-O. ophiodiicola activity

VOCs were tested individually in exposure assays to determine if specific compounds were antifungal against O. ophiodiicola. Previous research has shown numerous naturally-occurring VOCs to have antifungal activity. The following compounds were selected for VOC exposure assays in this study: N,N-dimethyloctylamine, benzothiazole, benzaldehyde, 2-phenylethanol, 2-ethyl-1-hexanol, propionic acid, 2-nonanone, decanal, styrene, and nonanal [17,19,21-23]. All VOCs were procured as pure liquid research-grade chemical reagents (Sigma- Aldrich, Missouri) without any modification for exposure assays. Single VOC exposures were performed at a quantity of 4.0 μmol on each absorbent disc in a closed air space (150 mm × 15 mm). Fungal plugs from a fresh mycelial lawn were inserted into a SDA Petri plate (60 mm × 15 mm) and placed in the closed airspace with the specific VOC disc. All assays were sealed with Parafilm M and incubated for 7 days at 30°C. Plugs were photographed every 24 hours in order to measure radial mycelial expansion. Each VOC was ranked according to the level inhibition of O. ophiodiicola in single-dose exposures performed in triplicate and averaged. Compounds were also ranked based on toxicity, according to median lethal dose (LD50) reported in the literature (S1). From those rankings, five VOCs were selected and paired in all different combinations with 2 μmols of each compound (4 μmol total) in a closed airspace. Similarly, the same 5 compounds were combined in combinations of 3 with 1.3 μmols of each compound in a closed airspace. N, N-dimethyloctylamine was excluded from the combination trials because of its high toxicity (S1) and replaced with the next most inhibitory compound, decanal (47.6%). The goal was to select the most effective compounds with the lowest reported toxicity (S1). All trials were performed in triplicate and radial mycelial growth was quantified over 7 days and averaged.

Area measurement of radial growth with digital photography and open-source software

The area of radial mycelial growth was determined using the open-source photo editing software package GIMP (GNU Image Manipulation Program). Area quantification of mycelia plugs were obtained according to the methods of Cornelison et al. [18].

Results

Co-culture assays with R. rhodochrous

Plates of induced cells of R. rhodochrous were placed in a closed airspace along with conidia-inoculated SDA Petri plates of O. ophiodiicola. 7 days post-inoculation, the Petri plates in a shared airspace with R. rhodochrous had no visible growth (Figure 1a) whereas the controls had formed a congruent lawn over the entire agar surface (Figure 1b).

veterinary-science-technology-Co-culture-assays

Figure 1: Co-culture assays with R. rhodochrous. 7 days post inoculation with 50 μl of 108 O. ophiodiicola conidia ml-1 in a closed airspace with induced R. rhodochrous (a) as well as in the absence of R. rhodochrous (b).

In the radial mycelial extension assays using vegetative mycelial plugs, R. rhodochrous produced statistically significant radial growth inhibition in days 3-6 post-inoculation (p<0.05, Figure 2). Radial area measurements on days 3, 5 and 6 showed a percent inhibition greater than 100%, due to the inhibited treatment plugs shrinking due to desiccation. Although the fungal plugs did show radial expansion in the first 24 hours post-inoculation, radial expansion was significantly inhibited in subsequent days (Figure 2).

veterinary-science-technology-Average-percent

Figure 2: Average percent inhibition of O. ophiodiicola radial expansion in a shared airspace with R. rhodochrous. *indicates statistically significant (p<0.05) inhibition compared to unexposed controls.

Induced R. rhodochrous germule suppression assay

O. ophiodiicola conidia on slide agar overlays were exposed to cells of induced R. rhodochrous on media in a closed airspace at 30°C for 24 and 48 hours (Figures 3b-3d). After removal of R. rhodochrous from the shared airspace the slides were monitored for 21 days to determine if the exposed conidia were capable of generating germules. These exposed slides were compared to the unexposed control slides inoculated with O. ophiodiicola conidia, which had over-grown the slide agar overlays after 8 days (Figure 3a). No germules were identified on slides exposed to R. rhodochrous whereas control slides showed significant mycelial growth and sporulation. These results validate the hypothesis that R. rhodochrous can inhibit germination of O. ophiodiicola with as little as 24 hours of exposure (Figure 3b).

veterinary-science-technology-Germule-suppression

Figure 3: Germule suppression assay. 50 μl of 106 O. ophiodiicola conidia ml-1 were inoculated on slide agars overlays and stored at 30°C. Images were captured 8 days post inoculation. The control exhibits normal growth characteristics. (a) 24 hr. exposure of R. rhodochrous inhibits germination and germules are unable to recover after exposure. (b) 48 hr. exposure to R. rhodochrous inhibits germination. (c) Experimental setup (d) Images a and b are captured at 400X and c is captured at 200X. Scale bars are 10 μm.

Anti-O. ophiodiicola activity of fermentation cell-paste

Non-growth cell-paste trials were conducted with 24 hour postharvest cell-paste (fresh), and 44 day-old cell-paste stored at 4°C (stored), to evaluate the influence of cold storage on the antifungal activity of R. rhodochrous fermentation cell-paste. Both fresh and stored cell-paste demonstrated inhibitory activity against O. ophiodiicola (Figure 4), although fresh cell-paste was quantitatively more inhibitory.

veterinary-science-technology-Biomass-compositio

Figure 4: Biomass composition, age and media support influence efficacy against O. ophiodiicola. Percent inhibition of stored paste (44 days at 4°C), fresh paste (<24 hours after harvesting from fermentation vessel) and induced plate cells (used while on induction agar). Percent inhibition was determined by comparing growth to unexposed controls, and averaged from triplicate.

Single VOC trials

O. ophiodiicola mycelial plugs were exposed to 4 μmol of ten different VOCs individually. The five most inhibitory VOCs were nonanal, 2-ethyl-1-hexanol, benzaldehyde, propionic acid, and N, N-dimethyloctylamine with averaged (n=3) percent inhibitions after 7 days of 80.6%, 80.5%, 52.9%, 59.0%, and 53.4% respectively (Figure 5).

veterinary-science-technology-Radial-growth

Figure 5: Radial growth of O. ophiodiicola with select VOCs.

Combinations of 2 VOCs

Overall combinations of 2 VOCs inhibited growth to a greater extent compared to the single VOC trials, supporting the hypothesis that select VOCs can work synergistically. The most effective combination was 2-ethyl-1-hexanol, and nonanal yielding an average of 94% inhibition over a period of 7 days (Figure 6). The second highest percent inhibition resulted from an equimolar combination of benzaldehyde, and 2-ethyl-1-hexanol, yielding an average of 93% inhibition over a period of 7 days (Figure 6).

Combinations of 3 VOCs

veterinary-science-technology-Radial-growth-equimolar

Figure 6: Radial growth of O. ophiodiicola with equimolar combinations of 2 VOCs.

All combinations of VOCs were more effective at inhibiting radial mycelial extension of O. ophiodiicola compared to any VOC alone at equivalent moles (Figure 7). The two combinations of 3 VOCs that had the highest percent inhibition were benzaldehyde, propionic acid, and nonanal yielding an average of 88% inhibition over a period of 7 days, and nonanal, 2-ethyl-1-hexanol, and propionic acid yielding an average of 85.1% inhibition of radial growth compared to controls (Figure 7).

veterinary-science-technology-Radial-growth-combinations

Figure 7: Radial growth of O. ophiodiicola with equimolar combinations of 3VOCs.

Discussion

Emerging fungal pathogens are threatening wildlife around the globe and have been reported to be increasing in incidence and severity over the past several decades [26]. Fungal pathogens present numerous challenges to disease management and microbial control efforts. This is primarily due to the ability of these fungi to thrive in host-free environmental reservoirs as well as their taxonomic similarity to their hosts (i.e., Eukarya/Eukarya). Consequently, antifungal agents used to treat human mycoses may have toxic effects on susceptible animals or be cost-prohibitive for large scale wildlife applications. Accordingly, the identification and evaluation of novel approaches to managing fungal pathogens of wildlife are needed to avert these potential ecological disasters.

Cases of SFD have increased significantly since 2006 [1]. Currently, SFD is confirmed in 15 states and continues to spread [1,2]. Disease management options for this mycosis are currently lacking, yet they may be vital to preventing regional extirpation of imperilled species such as the Eastern Massasauga Rattlesnake. The results presented in this study suggest that both R. rhodochrous and fungistatic soil-associated VOCs may have utility in managing SFD, and warrant additional, in vivo, evaluation [27,28]. Specifically, evaluating the potential of these agents to address the deep tissue granulomas characteristic of advanced SFD will be critical for establishing these agents as clinical tools in the treatment of SFD [29].

Rhodococcus rhodochrous, a naturally-occurring soil bacterium, can irreversibly inhibit spore germination (Figure 3) and significantly inhibit radial mycelial elongation (Figure 2). Complete inhibition of conidia is beneficial for disease management purposes because it prevents any remnant conidia from germinating and growing after the treatment is complete. Additionally, as with many fungal pathogens, spores are likely the primary transmittable disease agent. Rendering these spores nonviable may reduce the spread of SFD in addition to potentially ameliorating the effects of SFD on individual hosts [30,31].

The ability to produce induced R. rhodochrous in large-scale fermentations, store at 4°C, and retain antifungal activity establishes the logistical feasibility of this organisms for disease management applications. Additionally, the well-established utility and safety of this organism for diverse industrial applications is supportive of the benign nature of large-scale applications and environmental release, although the evaluation of the potential for non-target effects will need to be conducted to ensure safety prior to any in situ applications being considered [32,33].

Mycelial plug assays using VOCs have also produced favourable results. Individual VOCs produced significant inhibition, but even greater inhibition was observed when VOCs were used in equimolar combinations, with select combinations demonstrating significant synergistic activities. In addition, snakes are not a traditional model for toxicity assessments; therefore, the toxicity, as LD50 with rats, was used only as general estimate for ranking individual VOC toxicity. Using a low dosage of less toxic compounds can be used as a way to achieve impactful efficacy in fungal control and limit the potential toxicity associated with antifungal agents [34]. The efficacy of antifungal VOCs for in situ application in the control of SFD is currently unknown. There are several key factors which play a role in natural examples of fungistasis that will also influence field performance in managing SFD (for example, physical barriers to diffusion, humidity, airflow and temperature). These factors will vary from site to site and must be considered when evaluating to the potential of VOCs for in situ applications.

As the incidence and prevalence of emerging fungal pathogens expands, novel tools must be developed to facilitate active management of these pathogens. Fungal pathogens, such as O. ophiodiicola, are capable of surviving and potentially amplifying in host-free environments requiring environmental mitigations to reduce disease incidence within a population. In these cases, agents capable of rendering conidia non-viable may have significant utility and should be the focus of efforts to develop mitigation plans for SFD in atrisk populations. However, in vitro activity, such as reported in this manuscript, does not serve as an ideal predictor of efficacy in the field. While in situ disease management for wild snakes will be the ultimate goal for managing SFD, developing disease mitigation tools for application in the natural environment presents numerous challenges and necessitates further investigation. The initial findings presented in this manuscript justify further in vivo evaluation of R. rhodochrous and select VOCs for the clinical management of SFD in captive recovery programs and in captive collections (e.g., zoos, pet trade) [35,36].

Acknowledgments

This work was supported by the Environmental Research Center at Georgia State University as well as the Georgia State University Research Foundation.

Author Contributions

CTC, KTG, and SAC conceived and designed the experiments; BC performed the experiments; CTC, BC, and SAC analyzed the data; CKB and KTG contributed reagents/materials/analysis tools; CTC and BC wrote the paper. Conflicts of Interest

SAC is an inventor on the seminal patents on Rhodococcus rhodoochrous DAP 96253 induction and application. CTC and KTG are the inventors on a patent submission regarding VOC formulations for treating fungal disease. All issued and submitted patents relating to this work are held by the Georgia State University Research Foundation.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 8985
  • [From(publication date):
    November-2016 - Jul 23, 2018]
  • Breakdown by view type
  • HTML page views : 8865
  • PDF downloads : 120
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

putlockers

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version